Whenever, hepatitis C comes into picture, a sight of fear revolves around it. Today the fear isn’t related to the effect of this deadly disease but, it’s connected with the lesser known facts about it. People in absence of the right information and advice tend to be feared with the consequences of this disease.
One of the major concern and query that comes with the disease is related to its medicinal effectiveness. Some of the popular medicines that work wonders during the normal medication are questioned in different cases. There have been many queries coming up concerning the query that is Ledipasvir Sofosbuvir combination intake fruitful in case of transplant recipients.
Research has shown the effectively of Ledipasvir Sofosbuvir combination for the kidney transplant recipients who have been suffering from HEPATITIS C virus (HCV) with an infection of genotype 1 or 4. It has been validated that the treatment of a patient with ledipasvir sofosbuvir combination for 12 or 24 weeks is pretty safe and equally efficacious. As Hepatitis C is actually a silent killer.
One of the major concern and query that comes with the disease is related to its medicinal effectiveness. Some of the popular medicines that work wonders during the normal medication are questioned in different cases. There have been many queries coming up concerning the query that is Ledipasvir Sofosbuvir combination intake fruitful in case of transplant recipients.
Research has shown the effectively of Ledipasvir Sofosbuvir combination for the kidney transplant recipients who have been suffering from HEPATITIS C virus (HCV) with an infection of genotype 1 or 4. It has been validated that the treatment of a patient with ledipasvir sofosbuvir combination for 12 or 24 weeks is pretty safe and equally efficacious. As Hepatitis C is actually a silent killer.
According to a study conducted for examining the safety and efficacy of the interferon- and ribavirin-free combination of ledipasvir sofosbuvir in case of kidney transplant recipients, who were suffering from chronic genotype 1 or 4 HCV infection, it was found that 114 kidney transplant recipients (with/without compensated cirrhosis) showed healing, when treated with ledipasvir and sofosbuvir combination for a period of 12 or 24 weeks treatment. However, a few suffered from very mild side effects of headache, fatigue, asthenia, etc.Source from : Is Ledipasvir Sofosbuvir Safe For Transplant Recipients Suffering From Hepatitis C?
